Synthesis and Evaluation of Polycyclic Pyrazolo[3,4-<i>d</i>]pyrimidines as PDE1 and PDE5 cGMP Phosphodiesterase Inhibitors
Yan Xia(Stanford University), Hongtao Zhang(Chinese Academy of Sciences), Samuel Chackalamannil, Henry Vaccaro, Hsingan Tsai, John S. Cook, Ahmad Fawzi, Reneé Cleven, Robert W. Watkins, Michael Czarniecki(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 53
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271